These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Neuroprotective Effects of Agomelatine and Vinpocetine Against Chronic Cerebral Hypoperfusion Induced Vascular Dementia. Gupta S; Singh P; Sharma BM; Sharma B Curr Neurovasc Res; 2015; 12(3):240-52. PubMed ID: 26036976 [TBL] [Abstract][Full Text] [Related]
8. Selective modulator of cannabinoid receptor type 2 (CB2) against biochemical alterations and brain damage in chronic cerebral hypoperfusion induced vascular dementia. Jayant S; Sharma B Curr Neurovasc Res; 2016 Sep; ():. PubMed ID: 27599483 [TBL] [Abstract][Full Text] [Related]
9. Montelukast, a cysteinyl leukotriene receptor-1 antagonist protects against hippocampal injury induced by transient global cerebral ischemia and reperfusion in rats. Saad MA; Abdelsalam RM; Kenawy SA; Attia AS Neurochem Res; 2015 Jan; 40(1):139-50. PubMed ID: 25403620 [TBL] [Abstract][Full Text] [Related]
10. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist. Tuğtepe H; Sener G; Cetinel S; Velioğlu-Oğünç A; Yeğen BC Eur J Pharmacol; 2007 Feb; 557(1):69-75. PubMed ID: 17173892 [TBL] [Abstract][Full Text] [Related]
11. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice. Yu GL; Wei EQ; Zhang SH; Xu HM; Chu LS; Zhang WP; Zhang Q; Chen Z; Mei RH; Zhao MH Pharmacology; 2005 Jan; 73(1):31-40. PubMed ID: 15452361 [TBL] [Abstract][Full Text] [Related]
12. Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Aβ1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice. Lai J; Hu M; Wang H; Hu M; Long Y; Miao MX; Li JC; Wang XB; Kong LY; Hong H Neuropharmacology; 2014 Apr; 79():707-14. PubMed ID: 24456746 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological modulation of I(1)-imidazoline and α2-adrenoceptors in sub acute brain ischemia induced vascular dementia. Gupta S; Sharma B Eur J Pharmacol; 2014 Jan; 723():80-90. PubMed ID: 24333661 [TBL] [Abstract][Full Text] [Related]
14. Decreased cerebral perfusion and oxidative stress result in acute and delayed cognitive impairment. Liu H; Zhang J; Yang Y; Zhang L; Zeng X Curr Neurovasc Res; 2012 Aug; 9(3):152-8. PubMed ID: 22621229 [TBL] [Abstract][Full Text] [Related]
15. Chronic cerebral hypoperfusion-induced memory impairment and hippocampal long-term potentiation deficits are improved by cholinergic stimulation in rats. Damodaran T; Müller CP; Hassan Z Pharmacol Rep; 2019 Jun; 71(3):443-448. PubMed ID: 31003155 [TBL] [Abstract][Full Text] [Related]
16. Effect of ruthenium red, a ryanodine receptor antagonist in experimental diabetes induced vascular endothelial dysfunction and associated dementia in rats. Jain S; Sharma B Physiol Behav; 2016 Oct; 164(Pt A):140-50. PubMed ID: 27262216 [TBL] [Abstract][Full Text] [Related]
17. Neuronal damage, central cholinergic dysfunction and oxidative damage correlate with cognitive deficits in rats with chronic cerebral hypoperfusion. Xi Y; Wang M; Zhang W; Bai M; Du Y; Zhang Z; Li Z; Miao J Neurobiol Learn Mem; 2014 Mar; 109():7-19. PubMed ID: 24315928 [TBL] [Abstract][Full Text] [Related]
18. Antagonism of Endothelin (ETA and ETB) Receptors During Renovascular Hypertension-Induced Vascular Dementia Improves Cognition. Singh P; Gupta S; Sharma B Curr Neurovasc Res; 2016; 13(3):219-29. PubMed ID: 27189349 [TBL] [Abstract][Full Text] [Related]